Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Operating Expenses | 30,585 | 1,919 | 3,606 | 3,667 | 0 |
| Operating Income | -30,585 | -1,919 | -3,606 | -3,667 | N/A |
| Interest Expense | 3,054 | 5 | 0 | 0 | 0 |
| Other Income | -11,679 | -23 | -14 | -601 | 0 |
| Pre-tax Income | -45,318 | -1,948 | -3,620 | -4,268 | 0 |
| Net Income Continuous | -45,318 | -1,948 | -3,620 | -4,268 | N/A |
| Net Income | $-45,318 | $-1,948 | $-3,620 | $-4,268 | $N/A |
| EPS Basic Total Ops | -4,000.00 | -1,600.00 | -13,600.00 | -28,000.00 | N/A |
| EPS Basic Continuous Ops | -4,254.67 | -1,822.27 | -13,738.14 | -27,402.89 | N/A |
| EPS Diluted Total Ops | -4,000.00 | -1,600.00 | -13,600.00 | -28,000.00 | N/A |
| EPS Diluted Continuous Ops | -4,254.67 | -1,822.27 | -13,738.14 | -27,402.89 | N/A |
| EBITDA(a) | $-30,574 | $-1,914 | $-3,604 | $-3,665 | $N/A |